Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-β1 and bcl-2 expression

International Journal of Cancer

Volumn 69, Issue 5, 1996, Pages 357-363

  Tu, Huacheng ^a   Jacobs, Stephen C ^a   Borkowski, Andrej ^a   Kyprianou, Natasha ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ADENOCARCINOMA; APOPTOSIS; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029805136     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961021)69:5<357::AID-IJC1>3.0.CO;2-4     Document Type: Article

References (34)

1. AIHARA, M., SCARDINO, P.T., TRUONG, L.D., WHEELER, T.M., GOAD, J.R., YANG, G. and THOMPSON, T.C., The frequency of apoptosis correlates with the prognosis of Gleason grade in adenocarcinoma of the prostate. Cancer, 75, 522-529 (1995).
2. ARENDS, M.J. and WYLLIE, A.H., Apoptosis: mechanisms and roles in pathology. Int. Rev. exp. Pathol., 32, 223-250 (1991).
3. BARRES, B.A., HART, I.K., COLES, H.S.R., BURNE, J.F., VOYVODIC, J.T., RICHARD, W.D. and RAFF, M.C., Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70, 31-46 (1992).
4. BERGES, R.R., VUCANOVIC, J., EPSTEIN, J.I., CARMICHEL, M., CISEK, L., JOHNSON, D.E., VELTRI, R.N., WALSH, P.C. and ISAACS, J.T., Implication of cell kinetic changes during progression of human prostatic cancer. Clin. Cancer Res., 1, 473-480 (1995).
5. BORING, C.C., SQUIRES, T.S. and TONG, T., Cancer Statistics 1993. CA Cancer J. Pract., 43, 7-26 (1993).
6. BRONNER, M.P., CALIN, C., REED, J.C. and FURTH, E.E., The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Amer. J. Pathol., 146, 20-26 (1995).
7. CARTER, H.B. and COFFEY, D.S. Prostate, 16, 39-48 (1990).
8. CATTORETTI, G., BECKER, M.H.G., KEY, G., DUCHROW, M., SCHLUTER, C., GALLE, J. and GERDES, J., Monoclonal antibodies against recombinant parts of the Ki-67 antigen (M1B1) and (M1B3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363 (1992).
9. COLOMBEL, M.C., SYMMANS, F., GIL, S., O'TOOLE, K.M., CHOPIN, D., BENSON, M., OLSSON, C., KORSMEYER, S. and BUTTYAN, R., Detection of the apoptosis suppressing oncoprotein, bcl-2, in hormone-refractory human prostate cancers. Amer. J. Pathol., 143, 390-400 (1993).
10. EKLOV, S., FUNA, K., NORDGREN, H., OLOFSSON, A., KANZAKI, T., MIYAZOMO, K. and NILSSON, S., Lack of the latent transforming growth factor β binding protein in a malignant but not benign prostatic tissue. Cancer Res., 53, 3193-3197 (1993).
11. GAVRIELY, Y., SHERMAN, Y. and BENSASSON, S.A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501 (1992).
12. GLEASON, D.F., Histologic grading and clinical staging of prostatic carcinoma. In: M. Tannenbaum (ed.), Urologic Pathology. The Prostate, pp. 171-197, Lea and Febiger, Philadelphia (1977).
13. GLYNNE-JONES, E., HARPER, M.E., GODDARD, L., EATON, C.L., MATTHEWS, P.N. and GRIFFITHS, K., Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate, 25, 210-218 (1994).
14. HOCKENBERRY, D.M., ZUTLER, M., HICKEY, N., NAHM, M. and KORSMEYER, S.J., bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. nat. Acad. Sci. (Wash.), 88, 6961-6965 (1991).
15. ISAACS, J.T., Antagonistic effect of androgens on prostatic cell death. Prostate, 5, 545-558 (1984).
16. KERR, J.F.R., WYLLIE, A.H. and CURRIE, A.R., Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Brit. J. Cancer, 26, 239-257 (1992).
17. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate, 13, 103-118 (1988).
18. KYPRIANOU, N., ENGLISH, H.F. and ISAACS, J.T., Programmed cell death during regression of the PC-82 human prostate cancer following androgen ablation. Cancer Res., 50, 3748-3753 (1990).
19. KYPRIANOU, N. and ISAACS, J.T., Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology, 122, 552-562 (1988).
20. KYPRIANOU, N. and ISAACS, J.T., Expression of transforming growth factor-β in rat ventral prostate during castration induced programmed cell death. Mol. Endocrinol., 3, 1515-1522 (1989).
21. MASSAGUÉ, J., The transforming growth factor-β family. Ann. Rev. Cell Biol., 6, 597-641 (1990).
22. MCDONNEL, T.J., TRONCOSO, P., BRISBAY, S.M., LOGOTHETIS, C., CHUNG, L.W.K., HSIEH, J.-T., TU, S.-M., and CAMPBELL, M.L., Expression of the protoncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52, 6940-6944 (1992).
23. RAFF, M.C., Social controls on cell survival and cell death. Nature (Lond.), 356, 397-400 (1992).
24. REED, J.C., Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124, 1-6 (1994).
25. ROBERTS, A.B. and SPORN, M.B., The transforming growth factor-β. In: M.B. Sporn and A.B. Roberts (eds.), Handbook of experimental pharmacology of peptide growth factors and their receptors, pp. 419-472, Springer-Verlag, Heidelberg (1990).
26. ROTELLO, R.J., LIEBERMAN, R.C., PURCHIO, A.F. and GERSCHENSON, L.E., Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β in cultured murine epithelial cells. Proc. nat. Acad. Sci. (Wash.), 88, 3412-3415 (1991).
27. SAS INSTITUTE, SAS/STAT user's guide, version 6, vol. 2, GLMVARCOMP (4th ed.). SAS Institute, Cary, NC (1989).
28. SCHRÖDER, F.H., HERMANEK, P., DENIS, L., FAIR, W.R., GOSPODAROWICZ, M.K. and PAVONE MACALUSO, M., The TNM classification of prostate cancer. Prostate (Suppl.), 4, 129-138 (1992).
29. SHERWOOD, E.R., THEYER, G., STEINER, G., BERG, L.A., KOZLOWSKI, J.M. and LEE, C., Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate, Prostate, 18, 303-314 (1991).
30. STEEL, G.G., Growth kinetics of tumors, pp. 176-177. Clarendon, Oxford (1977).
31. STEINER, M. and BARRACK, E., Transforming growth factor β overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6, 15-25 (1992).
32. SUTKOWSKI, D.M., FONG, C.-J., SENSIBAR, J.A., RADEMAKER, E.D., SHERWOOD, E.R., KOZLOWSKI, J.M. and LEE, C., Interaction of epidermal growth factor and transforming growth factor β in human prostatic epithelial cells in culture. Prostate, 21, 133-143 (1992).
33. TRUONG, L.D., KADMON, D., MCCUNE, B., FLANDERS, K.C., SCARDINO, P.T. and THOMPSON, T.C., Association of TGF-β with prostate cancer: an immunohisto-chemical study. Hum. Pathol., 24, 4-9 (1993).
34. YANAGIHARA, K. and TSUMURAYA, M., Transforming growth factor β induces apoptotic cell death in cultured human gastric carcinoma cell. Cancer Res., 52, 4042-4045 (1992).